MyAverix Finance
US · Healthcare
Grifols SA ADR (GRFS)
Drug Manufacturers - General
Grifols SA ADR (GRFS) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GRFS
Grifols SA ADR (GRFS) — FAQ
What is GRFS's P/E ratio?
The price-to-earnings (P/E) ratio for Grifols SA ADR (GRFS) is 18.00 (data as of 2026-03-24).
Does Grifols SA ADR pay a dividend?
Dividend yield is not available in the current snapshot for Grifols SA ADR (GRFS). Check the MyAverix Finance app for the latest dividend data.
What sector is Grifols SA ADR in?
Grifols SA ADR (GRFS) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is GRFS listed on?
GRFS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.